🇺🇸 FDA
Pipeline program

OXALIPLATIN, FOLINIC ACID, IRINOTECAN, FLUOROURACIL

UC-0110/1609

Phase 3 small_molecule active

Quick answer

OXALIPLATIN, FOLINIC ACID, IRINOTECAN, FLUOROURACIL for High-risk stage III colon cancer is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cancer Prevention Pharma (Ireland) Limited
Indication
High-risk stage III colon cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials